Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Botanical research centers

This article was originally published in The Tan Sheet

Executive Summary

NCCAM and NIH's Office of Dietary Supplements are co-funding five-year grants for five research centers investigating "a variety of widely consumed botanicals from flaxseed to tarragon," NCCAM Director Stephen Straus, MD, announces April 7. The Memorial Sloan-Kettering Cancer Center in New York will research botanicals that may modulate immune function, including echinacea and Chinese herbal formulations. Metabolic syndrome, obesity and diabetes are the focus of a partnership between Rutgers and Louisiana State University. Other study areas include anti-inflammatory actions of botanical lipids at Wake Forest and Harvard; women's health at the University of Illinois-Chicago; and age-related diseases at Purdue, Rutgers and the University of Alabama. First-year funding for all five combined totals about $6.75 mil...

You may also be interested in...

Biogen ‘Ready To Launch’ Aducanumab If It Gets The Chance

The company has identified 600 sites of care to treat Alzheimer's patients with aducanumab in the US and is confident on its pricing strategy, management said.

Intuitive Exceeds Expectations In Q1 As Da Vinci Sales And Surgeries Recover

The robotic surgery company recorded $1.29bn in first-quarter revenue, an 18% year-over-year increase. Worldwide da Vinci procedures were up 16% as surgical volumes recovered from the pandemic.

California DTSC Eyes Hair Relaxers, Straighteners For Next Safer Consumer Product Priority

The Department of Toxic Substances Control does not identify specific chemicals of concern in its 2021-2023 Priority Product Draft Work Plan, but says it is focusing on ingredients and endpoints associated with children, women of childbearing age, communities of color and aquatic impacts.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts